Founder and CEO,
Dr. Heldman graduated from Harvard College (1984) with honors in the History of Science, the University of Alabama School of Medicine (1988), and took training in Internal Medicine (1991), Cardiovascular Disease and Interventional Cardiology (1995) all at Johns Hopkins Hospital. He was a faculty member in Interventional Cardiology at Johns Hopkins for another 12 years. In 2007 Dr. Heldman moved to the University of Miami Miller School of Medicine as Professor and Clinical Chief of Cardiology.
Dr. Heldman’s clinical practice specialized in complex and innovative catheter interventions. He performed hundreds of transcatheter valve replacements, hundreds of transendocardial stem cell injection procedures in human clinical trials, and many other structural heart interventions. His research program has centered on transcatheter and minimally invasive approaches to translate biological forces into clinical therapies. He was a member of the first team to produce a drug-coated coronary stent, and he has published extensively on the use of cellular therapeutics to regenerate damaged heart muscle.
Dr. Heldman’s inventions of novel devices for the delivery of therapies to the heart, and inventions in cell therapeutics (together with Dr. Joshua Hare and Dr. Konstantinos Chatzistergos) underlie the founding of Vestion, Inc. in 2012.